Groupe Regional d'Etudes du Cancer Colorectal Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2001
NCT00046995
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

carboplatin (paraplatin) (1 trial)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3